Bard Associates reports 102,831 shares (0.1%) in Modular Medical

Modular Medical, Inc. ownership update: Bard Associates, Inc. reports beneficial ownership of 102,831 shares of Common Stock as of 05/13/2026.

Rhea-AI Filing Summary

Modular Medical, Inc. ownership update: Bard Associates, Inc. reports beneficial ownership of 102,831 shares of Common Stock as of 05/13/2026. The filing states this represents 0.1% of the class, with 3,716 shares sole voting power and 99,115 shares subject to shared dispositive power.

Insights

Corporate Governance Analyst

Minor passive holder disclosure; no control signal.

Bard Associates, Inc. files an amended Schedule 13G/A reporting 102,831 shares (0.1%). The filing classifies the stake as under 5% and lists voting/dispositive powers, indicating passive investor status rather than an activist intent.

Timing: the amendment is dated 05/13/2026. Future filings could show material change if ownership grows above regulatory thresholds.

Key Figures

Beneficial ownership: 102,831 shares Percent of class: 0.1% Sole voting power: 3,716 shares +2 more

5 metrics

Beneficial ownership 102,831 shares Amount beneficially owned as reported

Percent of class 0.1% Percent of class as reported

Sole voting power 3,716 shares Sole power to vote as reported

Shared dispositive power 99,115 shares Shared power to dispose or direct disposition

Filing date / signature 05/13/2026 Amendment signed by Michael Demaray, President

Key Terms

Beneficially owned, Sole Voting Power, Shared Dispositive Power, Schedule 13G/A

4 terms

Beneficially owned regulatory

"Amount beneficially owned: 102831"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power regulatory

"Sole Voting Power 3,716.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Shared Dispositive Power regulatory

"Shared Dispositive Power 99,115.00"

Schedule 13G/A regulatory

"form_type: SCHEDULE 13G/A"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Bard Associates report in MODD?

Bard Associates reports beneficial ownership of 102,831 shares in Modular Medical, representing 0.1% of the class. The filing dated 05/13/2026 also discloses 3,716 shares with sole voting power and 99,115 shares with shared dispositive power.

Does this Schedule 13G/A indicate control of Modular Medical?

No: the filing states ownership is 0.1%, below 5%, which is consistent with passive investor reporting. It lists voting and dispositive allocations but does not assert control or activist intent in the disclosed items.

What do the voting and dispositive power numbers mean in the filing?

The filing shows 3,716 shares of sole voting and sole dispositive power, and 99,115 shares of shared dispositive power. These values allocate who can vote or direct sale decisions for the reported shares under SEC reporting rules.

When was the ownership amount reported and who signed the filing?

The amendment is dated 05/13/2026 and is signed by Michael Demaray, President. The filing lists Bard Associates, Inc. as the reporting person and provides its Chicago address in Item 2.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 02:00 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Modular Medical, Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

60785L306

(CUSIP Number)

05/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 60785L306

1

Names of Reporting Persons

Bard Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ILLINOIS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,716.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,716.00
8	Shared Dispositive Power 99,115.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

102,831.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.1 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Modular Medical, Inc
(b)	Address of issuer's principal executive offices: 10740 THORNMINT ROAD, SAN DIEGO, CA 92127
Item 2.
(a)	Name of person filing: Bard Associates, Inc.
(b)	Address or principal business office or, if none, residence: 233 South Wacker Drive, Suite 4400, Chicago, IL 60606
(c)	Citizenship: Illinois
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 60785L306
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 102831
(b)	Percent of class: 0.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3716
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3716
	(iv) Shared power to dispose or to direct the disposition of: 99115
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Bard Associates, Inc.

Signature:	Michael Demaray
Name/Title:	President
Date:	05/13/2026